8月抗體 “寶藏清單” 來啦！頂刊實驗室都在用
做實驗最怕工具掉鏈子！在此，我們精選了一批高品質(zhì)抗體，覆蓋單克隆、多克隆及熱門通路靶點抗體，不管是WB跑膠、IHC染色，還是IF成像、FCM分析，各類核心應(yīng)用場景都能輕松適配，給你的研究穩(wěn)穩(wěn)托底。不用再擔心抗體效價低、非特異結(jié)合拖后腿！現(xiàn)在鎖定這些優(yōu)質(zhì)抗體，直接跳過實驗試錯的坑，少走彎路快出結(jié)果，加速科研成果落地！
01 INV
產(chǎn)品貨號： PAB331Mu01
產(chǎn)品名稱：套膜蛋白(INV)多克隆抗體
文獻名稱：A mechano-resistance mechanism in skin adapts to terrestrial locomotion
雜志名稱：Cell
影響因子：42.5
PMID/DOI：40763735
發(fā)表日期：8/4/2025
發(fā)表單位：中國國家生物科學研究所，清華大學生命科學學院（清華大學-北京大學-北京生物科學研究所聯(lián)合培養(yǎng)項目）
樣本類型：小鼠爪部表皮組織
應(yīng)用類型：IHC
Immunofluorescence showed endogenous SLURP1 co-localizes with involucrin—a marker of the granular layer—but is absent from K14+ basal and K10+ spinous layers, indicating granular layer-specific expression of SLURP1 (Figure 3D).
02 PCNA
產(chǎn)品貨號：PAA591Mi01
產(chǎn)品名稱：抗增殖細胞核抗原(PCNA)多克隆抗體
文獻名稱：Discovery of a novel DNA aptamer for impeding tumor metastasis by blocking the functional activity of target protein on exosome
雜志名稱：Chemical Engineering Journal
影響因子：13.2
PMID/DOI：https://doi.org/10.1016/j.cej.2025.167253
發(fā)表日期：8/17/2025
發(fā)表單位 中國醫(yī)科大學細胞生物學系，衛(wèi)生部細胞生物學重點實驗室，教育部醫(yī)學細胞生物學重點實驗室
樣本類型：SW480荷瘤裸鼠的皮下腫瘤組織
應(yīng)用類型：IHC
(H–I) Subcutaneous tumor tissues were stained with anti-Ki67, anti-PCNA, anti-Caspase 3, anti-MMP-2, anti-Snail, and antiVEGFA antibodies, and differences in related proteins IHC scores were analyzed. (mean ± SD, n = 3; **p < 0.01, ***p < 0.001; unpaired two-tailed Student's ttest)
03 FcgBP
產(chǎn)品貨號： PAP389Hu01
產(chǎn)品名稱：IgG-Fc片段結(jié)合蛋白(FcgBP)多克隆抗體
文獻名：Using MUC2 mucin producing tumorigenic human goblet-like cells to uncover functional properties of the mucus barrier
雜志名：Gut Microbes
影響因子：11.0
PMID/DOI：40781862
發(fā)表日期：8/8/2025
發(fā)表單位 加拿大卡爾加里大學微生物學、免疫學與傳染病學系
樣本類型：人結(jié)腸腺癌LS174T細胞
應(yīng)用類型：IF
(F) Confocal microscopy images showing MUC2 (red), FCGBP (green), and DAPI (blue) in WT and Mut cells. Images are representative of five different experiments. Scale bar?=?10?μm.
04 IgG1
產(chǎn)品貨號：MAA074Hu22
產(chǎn)品名稱：免疫球蛋白G1(IgG1)單克隆抗體
文獻名：Multivalent fusion protein targeting VEGFR2 and DR5 receptors: assessing the antiangiogenic and antitumor effects via multimodal microangiography
雜志名：Journal of Translational Medicine
影響因子：7.5
PMID/DOI：40841907
發(fā)表日期：8/21/2025
發(fā)表單位 俄羅斯聯(lián)邦下諾夫哥羅德市 伏爾加流域研究醫(yī)科大學
樣本類型：人膠質(zhì)母細胞瘤U87MG細胞和人胰腺癌MIA PaCa-2細胞
應(yīng)用類型：FC
(A) Expression level of DR5, VEGFR2 and integrin αvβ3 receptors in U87MG and MIA PaCa-2 cell lines, flow cytometry;
05 MMP9
產(chǎn)品貨號：PAA553Mu01
產(chǎn)品名稱：基質(zhì)金屬蛋白酶9(MMP9)多克隆抗體
文獻名：Nitro-Substituted Benzylic Organochalcogenides as Anticancer Agents: Unravelling the Multifaceted Pathways to Combat Triple-Negative Breast Cancer
雜志名：Journal of Medicinal Chemistry
影響因子：6.8
PMID/DOI：40754986
發(fā)表日期：8/4/2025
發(fā)表單位 印度理工學院古瓦哈提分?；瘜W系
樣本類型：人乳腺癌MDA-MB-231細胞
應(yīng)用類型：WB
(A,B) Western blot analysis and the quantifications of proteins involved in TNF-α/NF-κB signaling pathways in MDA-MB-231 cells in the presence of compound 7 for 48 h. Data shown as mean ± SD (n = 3).